Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MammoScreen

Financiado

Innovative and safe microwave-based imaging technology to make breast cancer scr...

Innovative and safe microwave-based imaging technology to make breast cancer screening more accurate, inclusive and female-friendly Breast cancer (BC) is the most common cancer in women worldwide, affecting 1 in 8 women. The figures from WHO’s International Agency for Research on Cancer estimate that in 2020 worldwide cases of breast cancer accounted for 24% o... ver más

30/11/2026

TLS

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

FONDAZIONE TOSCANA LIFE SCIENCES No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 7 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-28

HORIZON-MISS-2021-CANCER-02-01: Develop new methods and technologie... ExpectedOutcome:Prevention is the most cost-effective long-term cancer control strategy. In EU-27 an...

I+D

Cerrada hace 2 años

0% 100% 100%

7 Participantes

TLS

3.18M€ | Lider

EVITA

316.25K€ | Participante

SERVICIO DE SALUD DE CASTILL...

776.25K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2019-110686RB-I00 CRIBADO COSTE-EFECTIVO DE CANCER DE MAMA MEDIANTE MAMOGRAFIA... 81K€ Cerrado

DPI2015-68442-R ANALISIS DE IMAGENES INTELIGENTE PARA LOS RETOS EN EL CRIBAD... 138K€ Cerrado

MONOBREAST Low-dose breast CT with monochromatic x-ray sources 150K€ Cerrado

RTC-2015-3287-1 Desarrollo de un algoritmo diagnóstico multimodal incluyendo... 193K€ Cerrado

RTI2018-096333-B-I00 COMPUTACION DE LA IMAGEN PARA LA MEJORA DE LA RADIOMICA DEL... 150K€ Cerrado

TED2021-130081B-C21 A COMPREHENSIVE COMPUTER-AIDED DIGANOSIS (CAD) SYSTEM BASED... 193K€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2022-11-28
Fecha Fin: 2026-11-30

Líder del proyecto

FONDAZIONE TOSCANA LIFE SCIENCES No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Descripción del proyecto Breast cancer (BC) is the most common cancer in women worldwide, affecting 1 in 8 women. The figures from WHO’s International Agency for Research on Cancer estimate that in 2020 worldwide cases of breast cancer accounted for 24% of all cancers in women (2.26 million women and 685,000 deaths globally). Mammography is the gold standard technology for breast screening, which has been demonstrated through different randomized controlled trials to reduce breast cancer mortality. However, it has limitations and potential harms, such as the use of ionizing radiation, breast compression and performance restrictions due to the intrinsic nature of X-rays. In particular, breast density is a restrictive property that can prevent breast cancer detection in mammograms of women with radiographically dense breasts. Other existing techniques (MRI, Ultrasound, biopsy) also suffer from drawbacks. The overall aim of the MammoScreen proposal is to generate evidence about the use of MammoWave (a technology developed by UBT) as screening technique in population-based programs promoted by National or Regional Health Systems, to reach a revolution in breast screening. To do so, the consortium aims to confirm that MammoWave reaches sensitivity>90% and specificity>95% in BC detection on 10000 study participants undergoing regular screening programs. MammoWave uses safe non-invasive and non-ionizing microwave signals, does not apply any compression to the breast and is very effective with dense breasts. Hence it can extend the breast screening to younger women aged 20-49 (98 million women in Europe). This group accounts for ~30% of breast cancers in 2020. A comprehensive health economic assessment will be undertaken in this project and innovative way to implement patient engagement approaches is sought. An effective policy makers’ engagement plan will be carried out to ensure that MammoWave is recommended as screening approach due to the benefits that it brings to women and healthcare systems. This action is part of the Cancer Mission cluster of projects on ‘Prevention, including Screening.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores